Skip to main content
BEONE MEDICINES LTD. logo

BEONE MEDICINES LTD. — Investor Relations & Filings

Ticker · 688235 ISIN · CNE100005XT6 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 727 across all filing types
Latest filing 2024-04-02 Share Issue/Capital Cha…
Country CN China
Listing Shanghai Stock Exchange 688235

About BEONE MEDICINES LTD.

https://beonemedicines.com/

BEONE MEDICINES LTD. is a biopharmaceutical company focused on the research, development, and commercialization of innovative therapeutic solutions, primarily in the field of oncology. The company specializes in the discovery of targeted small molecule drugs and biologics designed to address unmet medical needs in cancer treatment. Its research and development pipeline emphasizes precision medicine, utilizing advanced molecular biology and medicinal chemistry platforms to identify novel drug candidates. BEONE MEDICINES LTD. aims to improve patient outcomes by developing high-efficacy, low-toxicity therapies that target specific genetic drivers of disease. The company maintains a strong focus on clinical-stage development and strategic collaborations to advance its portfolio of next-generation medicines.

Recent filings

Filing Released Lang Actions
港股公告：翌日披露报表
Share Issue/Capital Change Classification · 95% confidence The document is a detailed disclosure report about changes in issued share capital and/or share repurchases by the company 百濟神州有限公司, registered in the Cayman Islands. It references specific Hong Kong Stock Exchange Listing Rules (Main Board Listing Rule 13.25A and GEM Listing Rule 17.27A) which require disclosure of share capital changes. The document includes detailed tables of share issuance, dates, share classes, prices, and percentages, as well as confirmations that the share issuances were authorized and complied with legal and listing requirements. The document length is 4179 characters, which is relatively short but contains substantive data on share capital changes rather than just an announcement or a link to a report. It is not an annual or interim financial report, nor a management or earnings report. It is not a proxy, voting result, or remuneration report. It is a regulatory disclosure specifically about share capital changes. Therefore, the most appropriate classification is Share Issue/Capital Change (SHA).
2024-04-02 Chinese
百济神州有限公司关于2024年年度股东大会股权登记日的公告
AGM Information Classification · 95% confidence The document is an announcement regarding the record date for shareholders to be eligible to attend and vote at the 2024 Annual General Meeting (AGM) of BeiGene Ltd. It specifies the record dates for different classes of shareholders across various stock exchanges and mentions that further details about the AGM will be disclosed later. The document does not contain the AGM materials or presentations themselves, nor does it include voting results or financial reports. It is a notice about the AGM logistics, specifically the share registration date for the AGM. Therefore, it fits the category of AGM Information (AGM-R). The document length is short and focused on the AGM event details, not the full report or results.
2024-03-28 Chinese
港股公告：百济神州有限公司截至2023年12月31日止年度全年业绩公告
Annual Report Classification · 100% confidence The document is a comprehensive financial report for BeiGene, Ltd. covering the full fiscal year ended December 31, 2023. It includes detailed financial statements such as consolidated balance sheets, income statements, cash flow statements, and equity statements. The report also contains extensive notes on accounting policies, segment information, and detailed disclosures about collaborations and licensing agreements. The presence of full financial data, comparative figures for the prior year, and detailed management discussion indicates this is a full annual report. The document is lengthy (15,000 characters) and contains substantive financial data, not merely an announcement or summary. Therefore, it fits the definition of an Annual Report (10-K). FY 2023
2024-03-28 Chinese
百济神州有限公司关于委任董事会商业及医学事务咨询委员会成员的公告
Board/Management Information Classification · 100% confidence The document is a short announcement (567 characters) regarding the appointment of a new member to the company's Board Commercial and Medical Affairs Advisory Committee. It includes details about the board committee members and the appointment date. There is no financial data, no report attached or referenced, and no mention of voting results or other report types. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2024-03-21 Chinese
美股公告：临时报告8-K表格
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the U.S. Securities and Exchange Commission (SEC) by BeiGene, Ltd. dated March 19, 2024. It reports the appointment of a new Chief Accounting Officer and amendments to the independent director compensation policy. The document includes detailed descriptions of the compensation policy changes and the appointment of a key management person. The 8-K form is used for current reports to announce major events that shareholders should know about, including management changes and compensation policy updates. This is not a full annual or quarterly report, nor an earnings release or proxy statement. It is a regulatory filing reporting management changes and compensation policy amendments. Therefore, the most appropriate classification is "Board/Management Information (MANG)" because it announces changes in senior management and board-related compensation policies. The document length and content confirm it is not a brief announcement but a substantive filing about management and governance changes.
2024-03-21 Chinese
港股公告：董事名单及其角色与职能
Board/Management Information Classification · 100% confidence The document lists the members of the board of directors and their roles and committee memberships. It is a detailed announcement about the company's board composition and governance structure. There is no financial data, no mention of a meeting or voting results, no presentation or call transcript, and no regulatory or legal updates. The content fits the category of Board/Management Information, which covers announcements of changes or details about the company's board of directors or senior management.
2024-03-21 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.